| HOME >> BIOLOGY >> TECHNOLOGY |
The table below is provided to assist the reader with comparability between the third quarter 2009 and the third quarter 2008 by providing consolidated and segment sales, EBITDA(1) and Adjusted EBITDA (2).
Consolidated and segment sales, EBITDA(1) and Adjusted EBITDA(2) three
months ended September 2009 and 2008
Three Months Ended September 30
From Continuing Adjust- 2009 Adjust- 2008
Operations ments As ments As %
(in millions) 2009 (3) Adjusted 2008 (3) Adjusted change
---- ----- -------- ---- ------ -------- ------
Net Sales
Saflex $182 $182 $221 $221 -18%
CPFilms 53 53 63 63 -16%
Technical
Specialties 209 209 294 294 -29%
Unallocated
and Other 4 4 9 9 -56%
--- --- --- --- ---
Total $448 $448 $587 $587 -24%
=== === === === ===
EBITDA(1)
Saflex $45 $2 $47 $36 $- $36 31%
CPFilms 11 1 12 15 - 15 -20%
Technical
Specialties 72 - 72 74 1 75 -4%
Unallocated
and Other (29) 17 (12) (17) 2 (15) 20%
--- --- --- --- --- --- ---
Total $99 $20 $119 $108 $3 $111 7%
=== === === === === === ===
(1) EBITDA is defined as earnings from continuing operations before
i
'/>"/>
| SOURCE Solutia Inc. Copyright©2009 PR Newswire. All rights reserved |